- Home
- FGI vs CNSP Comparison
FGI vs CNSP Comparison
Compare FGI & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- CNSP
- Stock Information
- Founded
- FGI 1987
- CNSP 2017
- Country
- FGI United States
- CNSP United States
- Employees
- FGI N/A
- CNSP N/A
- Industry
- FGI Industrial Specialties
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- CNSP Health Care
- Exchange
- FGI Nasdaq
- CNSP Nasdaq
- Market Cap
- FGI 5.1M
- CNSP 5.6M
- IPO Year
- FGI 2022
- CNSP 2019
- Fundamental
- Price
- FGI $0.72
- CNSP $1.04
- Analyst Decision
- FGI
- CNSP Hold
- Analyst Count
- FGI 0
- CNSP 1
- Target Price
- FGI N/A
- CNSP N/A
- AVG Volume (30 Days)
- FGI 408.9K
- CNSP 4.9M
- Earning Date
- FGI 05-13-2025
- CNSP 06-17-2025
- Dividend Yield
- FGI N/A
- CNSP N/A
- EPS Growth
- FGI N/A
- CNSP N/A
- EPS
- FGI N/A
- CNSP N/A
- Revenue
- FGI $134,277,102.00
- CNSP N/A
- Revenue This Year
- FGI $7.72
- CNSP N/A
- Revenue Next Year
- FGI $6.94
- CNSP N/A
- P/E Ratio
- FGI N/A
- CNSP N/A
- Revenue Growth
- FGI 11.13
- CNSP N/A
- 52 Week Low
- FGI $0.46
- CNSP $0.77
- 52 Week High
- FGI $1.36
- CNSP $414.00
- Technical
- Relative Strength Index (RSI)
- FGI 62.57
- CNSP 42.18
- Support Level
- FGI $0.67
- CNSP $1.00
- Resistance Level
- FGI $0.90
- CNSP $1.08
- Average True Range (ATR)
- FGI 0.07
- CNSP 0.09
- MACD
- FGI 0.02
- CNSP 0.00
- Stochastic Oscillator
- FGI 54.39
- CNSP 19.05
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.